Cargando…
Infections in Patients with Rheumatoid Arthritis in the Era of Targeted Synthetic Therapies
The third decade of the 21(st) century marks the beginning of a new era in the treatment of rheumatoid arthritis (RA). Recently, after the introduction in clinical practice of different biologics in the first decade, three different oral synthetic targeted agents (JAK inhibitors) have been licensed...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361184/ https://www.ncbi.nlm.nih.gov/pubmed/32676571 http://dx.doi.org/10.31138/mjr.31.1.129 |